The safety and efficacy of sirolimus/cyclosporine for the prevention of acute rejection in primary renal allograft recipients.

被引：0
|
作者：
Mathew, TH [1 ]
机构：
[1] Queen Elizabeth Hosp, Renal Unit, Adelaide, SA, Australia
来源：
TRANSPLANTATION | 2000年 / 69卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
957
引用
收藏
页码：S360 / S360
页数：1
相关论文
共 50 条
  • [1] Sirolimus is effective for prevention of acute rejection in primary mismatched renal allograft recipients
    Ponticelli, C
    [J]. TRANSPLANTATION PROCEEDINGS, 2001, 33 (1-2) : 1031 - 1032
  • [2] A worldwide, phase III, randomized, controlled, safety and efficacy study of a sirolimus/cyclosporine regimen for prevention of acute rejection in recipients of primary mismatched renal allografts
    MacDonald, AS
    [J]. TRANSPLANTATION, 2001, 71 (02) : 271 - 280
  • [3] Sirolimus in association with mycophenolate mofetil induction for the prevention of acute graft rejection in renal allograft recipients
    Kreis, H
    Cisterne, JM
    Land, W
    Wramner, L
    Squifflet, JP
    Abramowicz, D
    Campistol, JM
    Morales, JM
    Grinyo, JM
    Mourad, G
    Berthoux, FC
    Brattström, C
    Lebranchu, Y
    Vialtel, P
    [J]. TRANSPLANTATION, 2000, 69 (07) : 1252 - 1260
  • [4] Effects of immediate switch from cyclosporine microemulsion to tacrolimus at first acute rejection in renal allograft recipients.
    Briggs, D
    Dudley, C
    Pattison, J
    Pfeffer, P
    Salmela, K
    Rowe, P
    Tydén, G
    [J]. TRANSPLANTATION, 2003, 75 (12) : 2058 - 2063
  • [5] A pilot study of steroid-free immunosuppression in the prevention of acute rejection in renal allograft recipients.
    Cole, E
    Landsberg, D
    Russell, D
    Zaltzman, J
    Kiberd, B
    Caravaggio, C
    Vasquez, AR
    Halloran, P
    [J]. TRANSPLANTATION, 2001, 72 (05) : 845 - 850
  • [6] MYCOPHENOLATE MOFETIL FOR THE PREVENTION OF ACUTE REJECTION IN PRIMARY CADAVERIC RENAL-ALLOGRAFT RECIPIENTS
    SOLLINGER, HW
    [J]. TRANSPLANTATION, 1995, 60 (03) : 225 - 232
  • [7] FGF-23 Predicts Acute Rejection in Pediatric Renal Allograft Recipients.
    Tsai, Eileen W.
    Ettenger, Robert B.
    Reed, Elaine F.
    Juppner, Harald
    Salusky, Isidro B.
    Wesseling-Perry, Katherine
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2010, 10 : 484 - 484
  • [8] Efficacy of OKT3 as primary therapy for histologically confirmed acute renal allograft rejection in simultaneous kidney and pancreas transplant recipients.
    Peddi, VR
    Kamath, S
    Schroeder, TJ
    Munda, R
    First, MR
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1997, 8 : A3243 - A3243
  • [9] A retrospective analysis of a sirolimus/Prograf regimen for the prevention of acute rejection in recipients of primary mismatched renal allografts
    Youseff, N
    Small, S
    [J]. TRANSPLANTATION PROCEEDINGS, 2002, 34 (05) : 1653 - 1655
  • [10] Sirolimus: A new agent for prevention of renal allograft rejection
    Vazquez, EM
    [J]. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2000, 57 (05) : 437 - 448
12345